Evidence map›Paper›PMID 30554721›Full record

ArticleAmerican journal of human genetics2019

GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome.

Amy J LaCroix, Deborah Stabley, Rebecca Sahraoui, Margaret P Adam, Michele Mehaffey, Kelly Kernan, Candace T Myers, Carrie Fagerstrom, George Anadiotis, Yassmine M Akkari and 14 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. International journal of molecular sciences · 2025
    Article
  10. Article
  11. Article
  12. Expanding Upon Genomics in Rare Diseases: Epigenomic Insights.International journal of molecular sciences · 2024
    Review
  13. Article
  14. Considerations for reporting variants in novel candidate genes identified during clinical genomic testing.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 2 countries.

Amy J LaCroixDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA.
Deborah StableyNemours Biomedical Research Department, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
Rebecca SahraouiNemours Biomedical Research Department, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA; Biological Sciences, University of Delaware, Newark, DE 19716, USA.
Margaret P AdamDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
Michele MehaffeyDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA.
Kelly KernanDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA.
Candace T MyersSeattle Children's Hospital, Seattle, WA 98105, USA.
Carrie FagerstromLegacy Health, Portland, OR 97227, USA.
George AnadiotisLegacy Health, Portland, OR 97227, USA.
Yassmine M AkkariLegacy Health, Portland, OR 97227, USA.
Katherine M RobbinsNemours Biomedical Research Department, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
Karen W GrippNemours Biomedical Research Department, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
Wagner A R BaratelaDivision of Orthogenetics, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA; Instituto da Criança, Departamento de Pediatria, Universidade de São Paulo, São Paulo, SP Brazil.
Michael B BoberDivision of Orthogenetics, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
Angela L DukerDivision of Orthogenetics, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA.
Dan DohertyDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
Jennifer C DempseyDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA.
Daniel G MillerDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA.
Martin KircherDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Michael J BamshadDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA.
Deborah A NickersonBrotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA; Department of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
University of Washington Center for Mendelian Genomics
Heather C MeffordDepartment of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA 98195, USA; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195, USA. Electronic address: hmefford@uw.edu.
Katia Sol-ChurchNemours Biomedical Research Department, Alfred I. duPont Hospital for Children, Wilmington, DE 19803, USA; Department of Pathology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA. Electronic address: ks5uq@virginia.edu.
University of Washington · USAlfred I. duPont Hospital for Children · USLegacy Health · USBrotman Baty Institute · USSeattle Children's Hospital · USUniversidade de São Paulo · BRUniversity of Delaware · US

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Anjana Narayan Bhat · 2012 to 2026
$67.2M
UW Center for Mendelian GenomicsUM1HG006493 · NHGRI · UNIVERSITY OF WASHINGTON · PI BAMSHAD, MICHAEL JOSEPH, LEAL, SUZANNE M · 2016 to 2020
$15.3M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Center for Pediatric Research Pilot ProgramP30GM114736 · NIGMS · NEMOURS CHILDREN'S HOSPITAL, DELAWARE · PI SHAFFER, THOMAS H · 2015 to 2019
$5.1M
NHGRI Genome Sequencing Program Coordinating CenterU24HG008956 · NHGRI · RUTGERS, THE STATE UNIV OF N.J. · PI BUYSKE, STEVEN G, MATISE, TARA C. · 2016 to 2020
$4.9M
NHGRI NIH HHS U24 HG008956NHGRI NIH HHS UM1 HG006493NICHD NIH HHS U54 HD083091NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P30 GM114736
6 · The paper itself

Abstract

Baratela-Scott syndrome (BSS) is a rare, autosomal-recessive disorder characterized by short stature, facial dysmorphisms, developmental delay, and skeletal dysplasia caused by pathogenic variants in XYLT1. We report clinical and molecular investigation of 10 families (12 individuals) with BSS. Standard sequencing methods identified biallelic pathogenic variants in XYLT1 in only two families. Of the remaining cohort, two probands had no variants and six probands had only a single variant, including four with a heterozygous 3.1 Mb 16p13 deletion encompassing XYLT1 and two with a heterozygous truncating variant. Bisulfite sequencing revealed aberrant hypermethylation in exon 1 of XYLT1, always in trans with the sequence variant or deletion when present; both alleles were methylated in those with no identified variant. Expression of the methylated XYLT1 allele was severely reduced in fibroblasts from two probands. Southern blot studies combined with repeat expansion analysis of genome sequence data showed that the hypermethylation is associated with expansion of a GGC repeat in the XYLT1 promoter region that is not present in the reference genome, confirming that BSS is a trinucleotide repeat expansion disorder. The hypermethylated allele accounts for 50% of disease alleles in our cohort and is not present in 130 control subjects. Our study highlights the importance of investigating non-sequence-based alterations, including epigenetic changes, to identify the missing heritability in genetic disorders.

Indexed as

MutationAbnormalities, MultipleAllelesBlotting, SouthernCohort StudiesDNA MethylationEpigenesis, GeneticExonsFemaleHumansInfantInfant, NewbornMalePedigreePentosyltransferasesSulfiteshydrogen sulfitePentosyltransferasesSulfitesUDP Xylose-Protein Xylosyltransferase16p13 deletionDesbuquois dysplasiaepigeneticfragile sitemethylationrepeat expansionskeletal dysplasiatrinucleotide repeatXYLT1

Identifiers

PMID30554721
PMCPMC6323552
OpenAlexW2904037705

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.